1Life Healthcare (One Medical) Announces Pricing of Upsized Secondary Offering

NEXT STORY
Basilea announces partial repurchase offer for at least CHF 90 million and up to CHF 110 million in principal amount of its outstanding convertible bonds due 2022
PREV STORY
Evelo Biosciences Announces Pricing of Public Offering of Common Stock
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Positive Interim Results of CHOICE-01 Study Evaluating Coherus’ and Junshi Biosciences’ Toripalimab for First Line Treatment of Non-Small Cell Lung Cancer Presented at World Conference on Lung Cancer

author_avatar
NASDAQ Market News

Idera Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update

author_avatar
NASDAQ Market News

Generex Biotechnology Announces Webcast and Invites All Shareholders to See and Listen to the Corporate Presentation from the 21st Annual H.C. Wainwright Global Healthcare Investment Conference

author_avatar
NASDAQ Market News